Translational Studies 180214 Sep 2025 12:08
We should be getting some form of progress report in October with regards to the translational studies relating to 1802. This has been ongoing for a considerable time although I do understand that costs have to be tightly controlled when the cupboard is bare.
Oct 29 last year the update stated that proceeds from the recent subscriptions would also be used to accelerate 1802 translational studies. Since then, very little information or update. Hopefully it will come in from left field as a separate RNS or, at the very least, we should expect a progress report next month in the Chairman’s statement. I presume that if 1801 comes through with flying colours then 1802 should follow suit and very quickly. Compare scientific and manufacturing progress with the current market cap. Once we have clear and positive news these levels will be very much in the rear view mirror. DYOR and Best of luck to us all.